COLOBREATHE 1 662 500 IU, powder for inhalation in capsules 56 capsules
Active ingredients: Colistimethate sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for inhalation in capsules56 capsulesinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- COLOBREATHE 1 662 500 UI, poudre pour inhalation en gélule
- Pharmaceutical form
- poudre pour inhalation en gélule
- Route of administration
- inhalée
- Presentation description
- 7 plaquette(s) thermoformée(s) polyamide aluminium PVC de 8 gélule(s) avec inhalateur(s) Turbospin
- Marketing authorisation holder
- ESSENTIAL PHARMA (M) (MALTE)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 May 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65931808CIP72756943CIP133400927569432Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| COLISTIMÉTHATE SODIQUEpoudre | 125 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.